Overview
Hiroyoshi Kunimoto practices in Yokohama, Japan. Kunimoto is rated as an Advanced expert by MediFind in the treatment of VEXAS Syndrome. Their top areas of expertise are Myelodysplastic Syndrome (MDS), VEXAS Syndrome, Acute Myeloid Leukemia (AML), and Leukemia.
Their clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of VEXAS Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Myelodysplastic Syndrome (MDS)
- VEXAS SyndromeKunimoto isAdvanced. Learn about VEXAS Syndrome.
- Experienced
- Acute Myeloid Leukemia (AML)Kunimoto isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaKunimoto isExperienced. Learn about Anemia.
- Aplastic AnemiaKunimoto isExperienced. Learn about Aplastic Anemia.
- Bloom SyndromeKunimoto isExperienced. Learn about Bloom Syndrome.
- Chronic Myelomonocytic Leukemia (CMML)
- Constrictive PericarditisKunimoto isExperienced. Learn about Constrictive Pericarditis.